← Open Payments lookup

ERIKA WAYNIK: Open Payments

NPI 1700326410 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,030 in 62 payments from 14 companies in 2025. Trend: 2023 $748 · 2024 $1,492 · 2025 $1,030

Food & beverage: $1,030
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.10$201
Lundbeck LLC10$178
ABBVIE INC.19$158
Alkermes, Inc.4$84
Vanda Pharmaceuticals Inc.2$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$66
Otsuka America Pharmaceutical, Inc.2$65
Tris Pharma Inc4$62
Takeda Pharmaceuticals U.S.A., Inc.3$54
Janssen Pharmaceuticals, Inc1$26

Products named: COBENFY, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, ARISTADA, HETLIOZ, CAPLYTA, Dyanavel XR.

Industry payments across MD — which companies pay providers there.